Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-08-02
2011-08-02
Spector, Lorraine (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007210, C435S007950, C435S091100, C435S091200, C536S023100, C536S024310, C536S025300
Reexamination Certificate
active
07989167
ABSTRACT:
A method for diagnosing the presence of hereditary spastic paraplegia (HSP) or predicting the risk of developing HSP in a human subject, comprising detecting the presence or absence of a defect in a gene encoding a polypeptide comprising the sequence of FIG.9(SEQ ID NO: 19), in a nucleic acid sample of the subject, whereby the detection of the defect is indicative that the subject has or is at risk of developing HSP.
REFERENCES:
patent: WO 97/38085 (1997-10-01), None
Hedera et al., Am J Hum Genet., 64:563-569, 1999.
Nagase et al., DNA Res, 3(1):17-24, Feb. 1996.
Behan, W.M. and M. Maia, “Strümpell's Familial Spastic Paraplegia: Genetics and Neuropathology,”Journal of Neurology, 37:8-20 (1974).
Bourgeois, S. and D. Labuda, “Dynamic Allele-Specific Oligonucleotide Hybridization on Solid Support,”Anal. Biochem., 324:309-311 (2004).
Brand, M., et al., “Mutations Affecting Development of the Midline and General Body Shape During Zebrafish Embrygenesis,”Development, 123:129-142 (1996).
Casari, G., et al., “Spastic Paraplegia and OXPHOS Impairment Caused by Mutations in Paraplegin, a Nuclear-Encoded Mitochondrial Metalloprotease,”Cell, 93:973-983 (1998).
Cottingham, R.W., et al., “Faster Sequential Genetic Linkage Computations,”Am. J. Hum. Genet., 53:252-263 (1993).
DeLuca, G.C., et al. “The Extent of Axonal Loss in the Long Tracts in Hereditary Spastic Paraplegia,”Neuropathy Appl. Neurobiol,. 30:576-584 (2004).
Djinovic-Carugo, K., et al., “The Spectrin Repeat: A Structural Platform for Cytoskeletal Protein Assemblies,”FEBS Lett. 513:119-123 (2002).
Do, C.B., et al, “ProbCons: Probalistic Consistency-Based Multiple Sequence Alignment,”Genome Res., 15:330-340 (2005).
Fink, J.K., “Advances in Hereditary Spastic Paraplegia,”Current Opinion in Neurology, 10:313-318 (1997).
Finn, R.D., et al., “Pfam: Clains, Web Tools and Services,”Nucleic Acids Research, 34:D247-D251 (2006).
Guex, N., et al., “Swiss-Model and the Swiss PdbViewer An Environment for Comparative Protein Modeling,”Electrophoresis, 18:2714-2723 (1997).
Harding, A.E., “Classification of the Hereditary Ataxias and Paraplegias,”Lancet, 1:1151-1155 (1983).
Harding, A.E., “Hereditary Spastic Paraplegia,”Seminars in Neurology, 13:333-336 (1993).
Hazan, J., et al., “Spastin, a New AAA Protein, is Altered in the Most Frequent Form of Autosomal Dominant Spastic Paraplegia,”Nature Genetics, 23:296-303 (1999).
Hebsgaard, S.M., et al., “Splice Site Prediction inArabidopsis thalianapre-mRNA by Combining Local and Global Sequence Information,”Nucleic Acids Research, 24:3439-3452 (1996).
Hedera, P. et al., “Novel Locus for Autosomal Dominant Hereditary Spastic Paraplegia, on Chromosome 8q,”Am. J. Hum. Genet., 64:563-569 (1999).
Hirose, F., et al., “Novel 8-Base Pair Sequence (DrosophilaDNA Replication-Related Element) and Specific Binding Factor Involved in the Expression ofDrosophilaGenes for DNA Polymerase α and Proliferating Cell Nuclear Antigen,”Jour. Biol. Chem., 268:2092-2099 (1993).
Hochheimer, A., et al., “TRF2 Associates with DREF and Directs Promoter-Selective Gene Expression inDrosophila,” Nature, 420:439-445 (2002).
Ikeda, Y., et al., “Spectrin Mutations Cause Spinocerebellar Ataxia Type 5,”Nat. Genet., 38:184-190 (2005).
Ishikawa, K., et al., “An Autosomal Dominant Cerebellar Ataxia Linked to Chromosome 16q22.1 is Associated with a Single-Nucleotide Substitution in the 5′ Untranslated Region of the Gene Encoding a Protein with Spectrin Repeat and Rho Guanine-Nucleotide Exchange-Factor Domains,”Am. J. Hum. Genet., 77:280-296 (2005).
Jones, D.T., “Protein Secondary Structure Prediction Based on Position-Specific Scoring Matrices,”J. Mol. Biol., 292:195-202 (1999).
Jouet, M., et al., “X-Linked Spastic Paraplegia (SPG1), MASA Syndrome and X-Linked Hydrocephalus Result from Mutations in theLIGene,”Nat. Genet., 7:402-407 (1994).
Kelley, L.A., et al. “Enhanced Genome Annotation Using Structural Profiles in the Program 3D-PSSM,”J. Mol. Biol., 299:499-520 (2000).
Kent, W.J., et al., “The Human Genome Browser at UCSC,”Genome Res. 12:996-1006 (2002).
Klebe, S., et al., “Autosomal Recessive Spastic Paraplegia (SPG30) With Mild Ataxia and Sensory Neuropathy Maps to Chromosome 2q37.3,”Brain, 129:1456-1462 (2006).
Koenig, M., “The Complete Sequence of Dystrophin Predicts a Rod-Shaped Cytoskeletal Protein,”Cell, 53:219-228 (1988).
Labuda, D., et al., “Rapid Detection of CYP1A1, CYP2D6, and NAT Variants by Multiplex Polymerase Chain Reaction and Allele-Specific Oligonculeotide Assay,”Analytical Biochemistry, 275:84-92 (1999).
Mannan, A.U., et al., “ZFYVE27 (SPG33), a Novel Spastin-Binding Protein, is Mutated in Hereditary Spastic Paraplegia,”Am. J. Hum. Genet., 79:351-357 (2006).
McMonagle, P., et al. “The Prevalence of “Pure” Autosomal Dominant Hereditary Spastic Paraparesis in the Island of Ireland,”J. Neurol. Neurosurg. Psychiatry, 72:43-46 (2007).
Meijer, I.A., “Spectrum of SPG4 Mutations in a Large Collection of North American Families With Hereditary Spastic Paraplegia,”Arch. Neurol., 59:281-286 (2007).
Nasevicius, A. and S.C. Ekker, “Effective Targeted Gene ‘Knockdown’ in Zebrafish,”Nat. Genet., 26:216-220 (2000).
Polo, J.M., et al., “Hereditary Ataxias and Paraplegias in Cantabria, Spain,”Brain, 114:855-866 (1991).
Porkka, K.P., et al., “RAD21 and KIAA0196 and 8q24 are Amplified and Overexpressed in Prostate Cancer,”Genes Chromosomes&Cancer, 39:1-10 (2003).
Quevillon, E., et al., “InterProScan: Protein Domains Identifier,”Nucleic Acids Research, 33:W116-W120 (2005).
Reid, E., et al., “Autosomal Dominant Spastic Paraplegia,”Neurology, 53:1844-1849 (1999).
Rocco, P., et al., “Brazilian Family With Pure Autosomal Dominant Spastic Paraplegia Maps to 8q: Analysis of Muscle Beta 1 Syntrophin,”Am. J Med. Genet., 92:122-127 (2000).
Shimada, M., et al., “TATA-Binding Protein-Like Protein (TLP/TRF2/TLF) Negatively Regulates Cell Cycle Progression and is Required for the Stress-Mediated G2Checkpoint,”Mol. Cell Biol., 23:4107-4120 (2003).
Silva, M.C., et al., “Hereditary Ataxias and Spastic Paraplegias: Methodological Aspects of a Prevalence Study in Portugal,”J. Clin. Epidemiol., 50:1377-1384 (1997).
Soderblom, C. and C. Blackstone, “Traffic Accidents: Molecular Genetic Insights into the Pathogenesis of the Hereditary Spastic Paraplegias,”Pharmacol. Ther., 109:42-56 (2006).
Westerfield M., The Zebrafish Book. A Guide for Laboratory Use of Zebrafish (Danio rerio), Chapters 2-5, 7-8 C. Walker and G. Streisinger, (1994).
Wood, J.D., et al., “The Microtubule-Severing Protein Spastin is Essential for Axon Outgrowth in the Zebrafish Embryo,”Hum. Mol. Genet., 15:2763-2771 (2006).
Ylänne, J., et al., “Crystal Structure of the α-Actinin Rod: Four Spectrin Repeats Forming a Tight Dimer,”Cell. Biol. Mol. Lett. 6:234 (2001).
Züchner, S., et al., “A New Locus for Dominant Hereditary Spastic Paraplegia Maps to Chromosome 2p12,”Neurogenetics, 7:127-129 (2006).
Dion Patrick
Drapeau Pierre
Meijer Inge
Rouleau Guy A.
Valdmanis Paul
Hamilton Brook Smith & Reynolds P.C.
MacFarlane Stacey
Spector Lorraine
The Royal Institution for the Advancement of Learning/McGill Uni
Universite de Montreal
LandOfFree
Method of prognosing and diagnosing hereditary spastic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of prognosing and diagnosing hereditary spastic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of prognosing and diagnosing hereditary spastic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674735